Beneficial effects of dilazep on the palmitoyl-L-carnitine-induced derangements in isolated, perfused rat heart: Comparison with tetrodotoxin

被引:11
作者
Hara, A
Arakawa, J
Hashizume, H
Abiko, Y
机构
[1] Department of Pharmacology, Asahikawa Medical College
关键词
dilazep; tetrodotoxin; long-chain acylcarnitine; Na+ channel; heart (rat);
D O I
10.1254/jjp.74.147
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study was carried out to determine the effect of dilazep, having an inhibitory effect on the Na+ channel, on the mechanical dysfunction and metabolic derangements induced by palmitoyl-L-carnitine in isolated rat heart and to compare the effect of dilazep with that of tetrodotoxin, a specific inhibitor of the Na+ channel. Rat hearts were perfused aerobically at a constant flow according to Langendorff's technique and paced electrically. Palmitoyl-L-carnitine (5 mu M) decreased the left ventricular developed pressure and increased the left ventricular end diastolic pressure (i.e., it produced mechanical dysfunction), decreased the tissue level of adenosine triphosphate and increased the tissue level of adenosine monophosphate (i.e., it produced metabolic derangements). These mechanical and metabolic alterations induced by palmitoyl-L-carnitine were attenuated by either dilazep (1 mu M) or tetrodotoxin (3 mu M). On the other hand, neither dilazep nor tetrodotoxin modified the mechanical function and energy metabolism of the normal (palmitoyl-L-carnitine-untreated) heart. These results suggest that inhibition of the Na+ channel with dilazep or tetrodotoxin is responsible, at least in part, for attenuating the palmitoyl-L-carnitine-induced mechanical dysfunction and metabolic derangements in the heart.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 28 条
[1]  
Bergmeyer H. U., 1974, METHOD ENZYMAT AN, P1777
[2]   EXOGENOUS PALMITOYL CARNITINE AND MEMBRANE DAMAGE IN RAT HEARTS [J].
BUSSELEN, P ;
SERCU, D ;
VERDONCK, F .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1988, 20 (10) :905-916
[3]  
CATTERALL WA, 1981, MOL PHARMACOL, V20, P533
[4]  
Chiba K, 1995, ARCH INT PHARMACOD T, V330, P138
[5]   On the roles of long chain acyl carnitine accumulation and impaired glucose utilization in ischaemic contracture development and tissue damage in the guinea pig heart [J].
Clarke, B ;
Wyatt, KM ;
May, GR ;
McCormack, JG .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1996, 28 (01) :171-181
[6]   PROPHYLAXIS OF EARLY VENTRICULAR-FIBRILLATION BY INHIBITION OF ACYLCARNITINE ACCUMULATION [J].
CORR, PB ;
CREER, MH ;
YAMADA, KA ;
SAFFITZ, JE ;
SOBEL, BE .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (03) :927-936
[7]  
CORR PB, 1987, BASIC RES CARDIOL, V82, P199
[8]   AMPHIPATHIC LIPID METABOLITES AND THEIR RELATION TO ARRHYTHMOGENESIS IN THE ISCHEMIC HEART [J].
DATORRE, SD ;
CREER, MH ;
POGWIZD, SM ;
CORR, PB .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1991, 23 :11-22
[9]  
Hara A, 1996, J PHARMACOL EXP THER, V279, P32
[10]  
Hara A, 1995, ARCH INT PHARMACOD T, V330, P66